We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Parasitic Worms Cause Bile Duct Cancer

By LabMedica International staff writers
Posted on 27 Jul 2011
A parasitic liver fluke is thought to be associated with cancer of the bile duct, which is sometimes linked to eating uncooked freshwater fish.

In Thailand, health authorities are screening people infested with the worms for signs of the cancer especially as nearly all cases of cholangiocarcinoma develop in individuals with this infection.

The link between the cancer and the infection is now being investigated at the George Washington University School of Medicine and Health Sciences (Washington DC, USA) which has just been awarded a five year, US$500,000-per-year grant from the US National Cancer Institute (NCI; Bethesda, MA, USA). More...
The grant will support research into the development of proteomic biomarkers for Opisthorchis viverrini induced cholangiocarcinoma.

The scientists will use a quantitative proteomics approach to scan tumor tissues and matched plasma patients with cholangiocarcinoma to identify a suite of candidate biomarkers proximal to the disease site. Any potential biomarkers identified during the analysis of tumor tissue will be verified in the plasma of healthy individuals who are at risk for bile duct cancer from O. viverrini infection.

The global epicenter of cholangiocarcinoma is the region along the Chi River basin in Northeast Thailand, where infection with O. viverrini is endemic. The parasite is also endemic in Laos, Vietnam, and Cambodia, but it is difficult study cancer incidence in those countries. In Thailand, everyone above 30 years of age will get an annual stool examination to screen for fluke eggs. Those who are infected will be treated with drugs. O. viverrini is a food-borne parasite that is believed to infect more than 40 million people, primarily in Southeast Asia. Raw fish is the immediate host for the parasite and is a staple of the diet in that region.

Jeffrey M. Bethony, PhD, an associate professor of microbiology, said, "Bile duct cancer is associated with a late presentation, and there is no effective chemotherapy to treat the disease. Therefore, in addition to intervention strategies that focus on preventing or treating liver fluke infection, there is a need to identify biomarkers that can be measured early and in accessible samples.”

Related Links:
George Washington University
US National Cancer Institute


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: MG Tech adds STOMmics Stereo-seq spatial multi-omics technology to its potfolio (photo courtesy of STOmics)

MGI Tech Strengthens Sequencing Portfolio with Dual Acquisition

MGI Tech Co., Ltd. (Shenzhen, China) announced the acquisition of STOmics and CycloneSEQ on March 3, 2026, as part of its “SEQALL+GLI+Omics” strategy. According to the company, the combined portfolio spans... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.